ARTHQ (Arch Therapeutics) Dividends Received


ARTHQ Arch Therapeutics Inc ARTHQ
12 GF Score
Price $0.00
View Full Analysis

What is Arch Therapeutics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

ARTHQ
12GF Score
Arch Therapeutics Inc ARTHQ
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Therapeutics Business Description

Address 235 Walnut Street, Suite 6, Framingham, MA, USA, 01702
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
12GF Score

Get the complete analysis for ARTHQ

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price